ESS vs RNAC · P/E 31, rev $1.89B vs P/E 2.1, rev $38.9M
Essex Property Trust Inc (ESS) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the ESS and RNAC stock pages for the full models.
Not investment advice.